Trial intelligence / Profile preview

Phase II randomized study of intramuscular BK-PIFA (H5N1 influenza vaccine) in healthy children

jRCT2090220016Phase 2Completed

Sponsor
National Hospital Organization Mie National Hospital
Start
Apr 2008
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, open-label trial of inactivated Vero cell based whole virus influenza A/H5N1 in avian influenza (H5N1) (2 arms), sponsored by National Hospital Organization Mie National Hospital. Started Apr 2008; status: completed.

02

Drugs

inactivated Vero cell based whole virus influenza A/H5N1
03

Conditions

avian influenza (H5N1)

Beyond the preview

Go deeper on jRCT2090220016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2090220016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call